Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients

Judy Felgenhauer, Mary C. Hooke

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Adolescent and young adult (AYA) patients with cancer may face unique challenges if they and their families wish to participate in clinical oncology trials. Regulatory guidelines and funding requirements put in place to protect patients may actually raise barriers to enrollment in clinical trials. Hospital age guidelines may need to be readdressed to better suit the needs of AYA patients. Finally, the creation of the National Clinical Trials Network will provide new opportunities for pediatric and medical oncologists to collaborate in the care of AYA patients.

Original languageEnglish (US)
Pages (from-to)S119-S122
JournalPediatrics
Volume133
Issue numberSUPPL. 3
DOIs
StatePublished - Jun 1 2014

Keywords

  • AYA oncology
  • Regulatory barriers

Fingerprint

Dive into the research topics of 'Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients'. Together they form a unique fingerprint.

Cite this